14 articles, transcripts, and reports
Executive Summary ResMed has transitioned from a cyclical medical device manufacturer into a structurally growing digital health platform anchored in...
ResMed Inc (NYSE: RMD) FY 2026 Other Release
ResMed Inc (NYSE: RMD) Q2 2026 Earnings Conference
ResMed Inc (NYSE: RMD) Q2 2026 Earnings Call dated Jan. 29, 2026 Corporate Participants: Sallilyn Schwartz — Chief Investor Relations Officer Michael Farrell — Chief…
ResMed Inc (NYSE: RMD) Q2 2025 Earnings Call dated Jan. 30, 2025 Corporate Participants: Mike Ott — Senior Manager, Investor Relations Michael Farrell — Chief…
ResMed Inc (NYSE: RMD) Q3 2025 Earnings Call dated Apr. 23, 2025 Corporate Participants: Michael Farrell — Chief Executive Officer and Chairman of the Board…
ResMed Inc (NYSE: RMD) Q4 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Salli Schwartz — Chief Investor Relations Mick Farrell — Chairman of…
ResMed Inc (NYSE: RMD) Q1 2026 Earnings Call dated Oct. 30, 2025 Corporate Participants: Sallilyn Schwartz — Chief Investor Relations Officer Michael Farrell — Chairman…
ResMed Inc (NYSE: RMD) Q3 2022 Earnings Conference
ResMed inc (NYSE: RMD) Q2 2022 Earnings Conference
